Bin Luan Selected Research

Bin Luan Research Topics

Disease

16	Asthma (Bronchial Asthma) 01/2019 - 12/2006
12	Airway Remodeling 01/2019 - 09/2002
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Pneumonia (Pneumonitis) 01/2013 - 12/2008
2	Inflammation (Inflammations) 04/2012 - 02/2010
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Vascular Remodeling 04/2012
1	Brain Injuries (Brain Injury) 09/2011
1	Hypoxia (Hypoxemia) 09/2011
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 09/2011
1	Ischemia 09/2011
1	Infarction (Infarctions) 09/2011
1	Epilepsy (Aura) 05/2011
1	Wounds and Injuries (Trauma) 05/2009
1	Bacterial Pneumonia 12/2008

Drug/Important Bio-Agent (IBA)

10	OvalbuminIBA 01/2019 - 12/2006
7	Messenger RNA (mRNA)IBA 01/2017 - 03/2011
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2011
4	HMGB1 Protein (HMG1)IBA 01/2017 - 03/2014
3	Interleukin-4 (Interleukin 4)IBA 01/2017 - 05/2011
3	AerosolsIBA 02/2015 - 05/2009
3	Budesonide (Pulmicort)FDA LinkGeneric 01/2013 - 05/2009
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 01/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2013
2	Interleukin-12 (IL 12)IBA 01/2019 - 01/2013
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 01/2013
2	CytokinesIBA 01/2017 - 05/2011
2	Rosiglitazone (Avandia)FDA Link 05/2011 - 03/2011
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	Periodic AcidIBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	InterleukinsIBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Interleukin-17 (Interleukin 17)IBA 02/2015
1	SolutionsIBA 02/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015
1	Toll-Like Receptor 4IBA 03/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2013
1	MucinsIBA 01/2013
1	Interleukin-8 (Interleukin 8)IBA 04/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012
1	LipopolysaccharidesIBA 04/2012
1	CarnosineIBA 09/2011
1	Neuroprotective AgentsIBA 09/2011
1	Biomarkers (Surrogate Marker)IBA 09/2011
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 09/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2011
1	Levetiracetam (Keppra)FDA LinkGeneric 05/2011
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2011
1	LithiumIBA 05/2011
1	Pilocarpine (Ocusert)FDA LinkGeneric 05/2011
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 05/2011
1	GAP-43 Protein (GAP 43 Protein)IBA 05/2011
1	Staphylococcal Protein A (Protein A)IBA 03/2011
1	CXCR4 Receptors (CXCR4 Receptor)IBA 03/2010
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 02/2010
1	ErbB Receptors (EGF Receptor)IBA 02/2010
1	Tyrosine Kinase InhibitorsIBA 02/2010
1	Heparin (Liquaemin)FDA LinkGeneric 02/2010
1	Epidermal Growth Factor (EGF)IBA 02/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2010
1	RTKI cpdIBA 02/2010
1	CollagenIBA 02/2010
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2009
1	NF-kappa B (NF-kB)IBA 05/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2008
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2006
1	Angiotensin Receptor AntagonistsIBA 12/2006
1	PPAR gammaIBA 12/2004
1	AllergensIBA 09/2002
1	DNA (Deoxyribonucleic Acid)IBA 09/2002

Therapy/Procedure

3	Intraperitoneal Injections 02/2015 - 05/2009
2	Therapeutics 01/2019 - 01/2019
1	Transplantation 01/2019
1	Length of Stay 12/2008